Press release
Bile Duct Cancer Market Worldwide Top Players Success Millstones by Revenue, Size and Shares Forecasts Till 2023
The International Bile Duct Cancer Market report Forecasts the Industry Drivers and Major Regions Till 2023. According to the National Cancer Institute, in 2014, there were an estimated 66,771 cases of intrahepatic bile duct cancer in the U.S. Moreover, the disease is expected to cause 28,920 deaths by the end of 2017 accounting for 4.8% of all cancer deaths. Death rates have been rising on average 2.6% each year over 2005-2014. Such an increasing prevalence of the bile duct cancer will boost the market during the forecast period. Moreover, rising healthcare expenditure, increasing awareness for the disease, and investments in the R&D for treatment procedures is fuelling the market growth. Bile duct cancer is a rare type of neoplasm in which epithelial cells of the bile duct are mutated and show epithelial differentiation. Bile duct cancer be diagnosed using blood tests, abdominal imaging, surgery, and others.However, high cost of treatment and related side effects along with low healthcare expenditures in the developing economies is expected restrain the market growth during the forecast period. According to the Centres for Disease Control and Prevention (CDC), U.S. health care spending in 2015, reached USD 3.2 trillion or USD 9,990 per person which accounted for 17.8% of the total GDP. Moreover, the presence of the global market leaders like Pfizer Inc. and Bristol-Myers Squibb Company within the region fuels the market growth during the forecasted period.
Get Exclusive Sample Copy @ https://www.marketresearchfuture.com/sample_request/4741 .
Key Players in the Bile Duct Cancer Market:
Pfizer Inc. (U.S.), F. Hoffmann-La Roche Ltd (Europe), Bristol-Myers Squibb Company (U.S.), Teva Pharmaceutical Industries Ltd. (Isreal), Eli Lilly and Company. (U.S.), Sanofi (France), Fresenius Kabi AG (Germany), Mylan N.V. (U.S.), and others.
Key Developments:
Strategic approaches adopted help the major players in the market to sustain their growth and develop their business in various geographical areas across the globe. Agreements and collaborations, mergers and acquisitions, and new product launches are various strategies followed by the key players.
Pfizer Inc.:
Pfizer Inc. is an American global pharmaceutical corporation headquartered in New York City. It is among the world's largest pharmaceutical companies. Pfizer develops and produces medicines and vaccines for a wide range of medical disciplines, including immunology, oncology, cardiology, diabetology/endocrinology, and neurology. Anti-malaria drugs developed by the company include Metakelfin, Camoquin and Dualkin.
December 2017: Pfizer Inc. and Basilea Pharmaceutica Ltd., a biopharmaceutical company specializing in the research and development of anti-infective and oncological medicines, entered into an agreement in which Pfizer will grant the exclusive development and commercialization rights in China and several countries in the Asia Pacific region to CRESEMBA (isavuconazole). CRESEMBA is a novel antifungal medicine for the treatment of adult patients with diagnosed invasive aspergillosis and mucormycosis1, resulting in mortality among patients with HIV and cancer. The rights for distribution and commercialization of CRESEMBA in sixteen Asian Pacific countries and China (including Hong Kong and Macao) will lay with Pfizer, excluding Japan. Furthermore, Pfizer will be responsible for marketing authorization holder for the Asia Pacific Region and China.
July 2017: Pfizer completed an agreement with Basilea to obtain the exclusive commercialization rights to CRESEMBA in Europe (with the exception of the Nordic countries). Since that time, Pfizer has assumed responsibility for the commercialization of CRESEMBA in Austria, France, Germany, Italy, and the United Kingdom and successfully launched CRESEMBA in Spain with additional launches expected in 2018 and beyond.
Teva Pharmaceutical Industries ltd:
July, 2017: Teva Pharmaceutical Industries Ltd. announced the launch of a generic version of Vagifem 1 (estradiol vaginal inserts), 10 mcg in the U.S. it is indicated for the treatment of atrophic vaginitis due to menopause. This adds to the company’s more than 70 products in women’s health segment. The launch will help the company to expand portfolio of oral contraceptives and hormone replacement therapies providing range of products for women health.
July, 2017: Teva Pharmaceutical Industries Ltd. announced the launch of generic Epiduo 1 (adapalene and benzoyl peroxide) gel, 0.1%/2.5% in the U.S. Adapalene and benzoyl peroxide gel are indicated for the topical treatment of acne vulgaris in patients 9 years of age and older. This launch will help the company to strengthen it market in the U.S. and maintain product diifertiation.
September, 2016: Teva Pharmaceutical Industries ltd signed a multi-project alliance agreement with Cancer Research Technology Ltd. (CRT), U.K to develop first-in-class cancer drugs that modulate DNA damage and repair response (DDR) processes in cancer cells. DDR will protect cancer cells from the damaging effect of chemotherapy.
Order a Single User Premium 85 Pages Copy @ https://www.marketresearchfuture.com/checkout?currency=one_user-USD&report_id=4741 .
Major TOC Bile Duct Cancer Market:
1 Report Prologue
2 Market Introduction
2.1 Introduction
2.2 Scope of Study
2.3 Research Objective
2.4 Assumptions & Limitations
2.4.1 Assumptions
2.4.2 Limitations
3 Research Methodology
3.1 Research Process
3.2 Primary Research
3.3 Secondary Research
Continued….
Ask Questions to Expertise @ https://www.marketresearchfuture.com/enquiry/4741 .
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Bile Duct Cancer Market Worldwide Top Players Success Millstones by Revenue, Size and Shares Forecasts Till 2023 here
News-ID: 931042 • Views: …
More Releases from Market Research Future

9-Decanoic Acid Methyl Ester Market Poised for Strong 6.59% CAGR Growth Through …
The 9-decanoic acid methyl ester market is a growing sector driven by the increasing demand for bio-based and sustainable chemical products across various industries. With its unique properties, it finds application in flavors and fragrances, pharmaceuticals, personal care, and as a chemical intermediate. The market is projected to expand significantly in the coming years.
Market Overview and Size
The global 9-decanoic acid methyl ester market was valued at USD 230.0 million in…

Washable Marker Market Poised for 3.54% CAGR Growth During 2024-2032
The washable marker market is a dynamic and growing segment within the broader stationery and art supplies industry. Driven by a blend of consumer demands for safety, convenience, and sustainability, the market is experiencing consistent expansion, particularly within the education and home-use sectors. While faced with some challenges, the industry's future looks promising, propelled by product innovation and evolving consumer trends.
Get Sample @ https://www.marketresearchfuture.com/sample_request/41217
Market Size and Growth
The global washable…

Phone Car Mounts Market to Reach USD 7.37 Billion by 2034, Growing at 6.47% CAGR
The phone car mounts market, a critical sub-segment of the broader automotive accessories industry, is experiencing robust growth driven by a convergence of technological advancements, evolving consumer behavior, and increasingly stringent road safety regulations. As smartphones become indispensable for navigation, communication, and in-car entertainment, the demand for secure and convenient hands-free solutions continues to escalate. The global phone car mounts market was valued at USD 3.93 billion in 2024 and…

Intravenous (IV) Solution Market Set to Grow to USD 26.60 Billion at 7.70% CAGR …
Market Overview:
The Intravenous (IV) Solution Market is estimated to be valued at USD 13.9 billion in 2023 and is projected to reach USD 26.60 billion by 2032, expanding at a compound annual growth rate (CAGR) of 7.70% from 2024 to 2031. The market growth is attributed to the rising prevalence of chronic diseases, growing hospitalization rates, and increasing surgical procedures that require IV fluid administration. Intravenous solutions are critical…
More Releases for Pfizer
Oligodendroglioma Market to Witness Growth by 2032 | Companies- EpicentRx, Pfize …
DelveInsight's "Oligodendroglioma Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Oligodendroglioma, historical and forecasted epidemiology as well as the Oligodendroglioma market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.
The Oligodendroglioma market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and the current and forecasted Oligodendroglioma market size from 2019 to 2032, segmented…
Pfizer Indian Offices in a BioBubble
Kolkata, December 2021 - “Our science holds the cure”, Pfizer believes. One of the leading World’s Premier Pharmaceutical and Biotech Corporation Company Pfizer delivers wellness, prevention, treatment, and cure to combat the most feared diseases.
Pfizer appreciated and implemented this revolutionary idea of disinfection by Chemtex, going by the name of BioBubble. Pfizer, a research-based global biopharmaceutical company has taken steps to protect their high foot traffic points and potential hotspots…
Pediatric Vaccines Market is demanded globally by Key Players Merck & Co. Inc., …
This detailed market study covers Pediatric Vaccines Market growth potentials which can assist the stake holders to understand key trends and prospects in Pediatric Vaccines market identifying the growth opportunities and competitive scenarios. The report also focuses on data from different primary and secondary sources, and is analyzed using various tools. It helps to gain insights into the market's growth potential, which can help investors identify scope and opportunities. The…
Global Pentostatin Market 2019 Scenario of Top Sellers: • Hospira (Pfizer),• …
The "Pentostatin market" study formulated by Up Market Research, presents a detailed analysis of the influential trends prevailing in this business sphere. This research report also offers definitive information concerning the commercialization of this vertical, market size, and revenue estimation of this industry. The study explicitly illustrates the competitive standing of key players over the projected timeline while incorporating their individual portfolios & geographical expansion.
The Global Pentostatin market 2019…
Migraine Drugs Market Research Exclusive Report 2019-2025 | Top Key Players Alle …
UpMarketResearch offers a latest published report on “Global Migraine Drugs Market Analysis and Forecast 2018-2025” delivering key insights and providing a competitive advantage to clients through a detailed report. The report contains 123 pages which highly exhibit on current market analysis scenario, upcoming as well as future opportunities, revenue growth, pricing and profitability.
Get Exclusive FREE Sample Copy Of this Report @ https://www.upmarketresearch.com/home/requested_sample/46396
Migraine Drugs Market research report delivers…
Pentostatin Market Research Report Global Forecast 2018-25 Estimated with Top Ke …
UpMarketResearch published an exclusive report on “Pentostatin market” delivering key insights and providing a competitive advantage to clients through a detailed report. The report contains 116 pages which highly exhibits on current market analysis scenario, upcoming as well as future opportunities, revenue growth, pricing and profitability. This report focuses on the Pentostatin market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the…